AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Home

Washington Highlights

Testimony & Correspondence

Top Issues:

 

Education

 

GME & IME Payments

HIPAA

Labor-HHS Appropriations

Research

Teaching Hospitals

Teaching Physicians

Veterans Affairs

Workforce

Government Affairs & Advocacy Site Map

Contact

 

Government Affairs Home > Washington Highlights > January 9, 2004

NIH Issues Final Rule on Peer Review Committees

January 9, 2004 - After several years in process, the Department of Health and Human Services (DHHS) and NIH have finalized revised regulations on the conduct of scientific peer review of NIH research grants and R&D contracts (69 Federal Register 272). When first proposed in September 2000, the regulations were needed to clarify the status and requirements for peer review study sections, which differ from NIH advisory councils or similar bodies that are subject to the Federal Advisory Committees Act.

Notable revisions in the new regulations pertain to reviewers' Conflicts of Interest, and establish wide-ranging criteria for determining "real" and "apparent" conflicts. A real conflict of interest, for example, includes a non-salary financial benefit of $10,000 or more that a reviewer (or reviewer's close family or colleagues) receives from an organization or individual submitting a research proposal. The rule requires disclosure of such conflicts and recusal of reviewers as necessary, and allows for reconsideration of conflicts by the NIH director. In its comment letter of Nov. 20, 2000, the AAMC encouraged NIH's revision of these regulations, but argued that the distinction between real and apparent conflicts is artificial and misleading: all conflicts of interest involve questions of perception as to potential for bias or partiality, and should be addressed accordingly. The AAMC had also recommended that the threshold for determining financial benefit be made consistent with other federal regulations, which the new rule does accomplish.

Information:

Stephen Heinig, Lead Science Policy Analyst
AAMC Biomedical Health Sciences Research
sheinig@aamc.org
(202) 828-0488

e-mail icon Get Washington Highlights in your Inbox!

Contact Us    © 1995-2008 AAMC    Terms and Conditions    Privacy Statement